PEGINTERFERON Side Effects

6881369-5 | Abnormal Behaviour, Decreased Appetite, Liver Function Test Abnormal, Nausea, Paranoia
on Jul 28, 2010 Male patient from UNITED STATES , 49 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Peginterferon (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, decreased appetite, liver function test abnormal, nausea (What is nausea?), paranoia. Peginterferon dosage: 180 Mcg Qweek Sq. During the same period patient was treated with RIBAVIRIN (400 Mg Bid Po) (View Ribavirin Review and Ribavirin Label ). Patient was hospitalized.

6822434-8 | Anaphylactic Reaction, Angioedema, Dyspnoea, Rash
Patient was taking Peginterferon (View Usage). Patient had the following side effects: anaphylactic reaction, angioedema, dyspnoea, rash (What is rash?) on Jul 07, 2010 from UNITED STATES Additional patient health information: Male patient , 56 years of age, weighting 192.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Peginterferon dosage: 180 Mcg Qweek Sq.

6722877-7 | Gangrene, Idiopathic Thrombocytopenic Purpura
Adverse event was reported on May 12, 2010 by a Male patient taking Peginterferon (View Usage) (Dosage: 180 Mcg Qweek Sq) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , 50 years of age, weighting 152.1 lb, After Peginterferon was administered, patient had the following side effects: gangrene, idiopathic thrombocytopenic purpura. During the same period patient was treated with RIBAVIRIN (600 Mg Am Po) (View Ribavirin Review and Ribavirin Label ). Patient was hospitalized.

6720534-4 | Dry Skin, Erythema Multiforme, Skin Exfoliation, Superinfection
on May 11, 2010 Male patient from UNITED STATES , 58 years of age, weighting 240.1 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Peginterferon (View Usage). Patient experienced the following unwanted or unexpected effects: dry skin, erythema multiforme, skin exfoliation, superinfection. Peginterferon dosage: 180 Mg Qweek Sq. Patient was hospitalized.


6719203-6 | Eye Pain, Retinal Exudates, Retinopathy
on May 10, 2010 Male patient from UNITED STATES , 54 years of age, weighting 179.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Peginterferon (View Usage). Patient had the following side effects: eye pain, retinal exudates, retinopathy. Peginterferon dosage: 180 Mcg Qweek Sq.

6713293-2 | Dizziness, Nausea, Syncope
Patient was taking Peginterferon (View Usage). After Peginterferon was administered, patient had the following side effects: dizziness (What is dizziness?), nausea (What is nausea?), syncope on May 05, 2010 from UNITED STATES Additional patient health information: Male patient , 64 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Peginterferon dosage: 180 Mg Qweek Po.

6647532-3 | Febrile Neutropenia, Pancytopenia, Pneumonia
Adverse event was reported on Mar 23, 2010 by a Male patient taking Peginterferon (View Usage) (Dosage: 180 Mcg Qweek Sq) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , 61 years of age, weighting 218.4 lb, Patient experienced the following unwanted or unexpected effects: febrile neutropenia, pancytopenia, pneumonia (What is pneumonia?). During the same period patient was treated with RIBAVIRIN (1400 Mg Every Day Po) (View Ribavirin Review and Ribavirin Label ). Patient was hospitalized.

6582347-6 | Anaemia Haemolytic Autoimmune
on Feb 12, 2010 Male patient from UNITED STATES , 65 years of age, weighting 191.1 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Peginterferon (View Usage). Patient had the following side effects: anaemia haemolytic autoimmune. Peginterferon dosage: 180 Mg Qweek Sq. During the same period patient was treated with RIBAVIRIN (180 Mg Qweek Sq) (View Ribavirin Review and Ribavirin Label ). Patient was hospitalized.

6492978-X | Diarrhoea
on Dec 11, 2009 Male patient from UNITED STATES , 52 years of age, weighting 154.6 lb, was treated with Peginterferon (View Usage). After Peginterferon was administered, patient had the following side effects: diarrhoea. Peginterferon dosage: 96 Mcg Qweek Sq. During the same period patient was treated with RIBAVIRIN (96 Mcg Q Week Sq) (View Ribavirin Review and Ribavirin Label ). Patient was hospitalized.

6389608-4 | Diarrhoea, Myalgia, Nausea
Patient was taking Peginterferon (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, myalgia, nausea (What is nausea?) on Oct 02, 2009 from UNITED STATES Additional patient health information: Male patient , 52 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Peginterferon dosage: 180 Mcg Qweek Sq. During the same period patient was treated with RIBAVIRIN (400 Mg Bid Po) (View Ribavirin Review and Ribavirin Label ). Patient was hospitalized.

6389604-7 | Dermatitis, Musculoskeletal Pain, Onychomadesis, Pain In Extremity, Psoriasis, Psoriatic Arthropathy, Skin Exfoliation
Adverse event was reported on Oct 02, 2009 by a Male patient taking Peginterferon (View Usage) (Dosage: 180 Mcg Qweek Sq) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , 46 years of age, weighting 175.7 lb, Patient had the following side effects: dermatitis, musculoskeletal pain, onychomadesis, pain in extremity, psoriasis, psoriatic arthropathy, skin exfoliation. Patient was hospitalized.

6369115-5 | Hypertension, Neuropathy Peripheral
on Sep 18, 2009 Male patient from UNITED STATES , 60 years of age, weighting 165.0 lb, was diagnosed with hepatitis (What is hepatitis?) and was treated with Peginterferon (View Usage). After Peginterferon was administered, patient had the following side effects: hypertension, neuropathy peripheral. Peginterferon dosage: Unsure Weekly Intervenious. During the same period patient was treated with RIBAVIRIN (200mg Daily Oral) (View Ribavirin Review and Ribavirin Label ). Patient was hospitalized and became disabled.

5573114-0 | Nephritis
on Dec 20, 2007 Male patient from UNITED STATES , 53 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Peginterferon (View Usage). Patient experienced the following unwanted or unexpected effects: nephritis. Peginterferon dosage: 180mcg Qweek Sq. During the same period patient was treated with RIBAVIRIN (600mg Bid Po) (View Ribavirin Review and Ribavirin Label ). Patient was hospitalized.

5315704-6 | Pancreatitis
Patient was taking Peginterferon (View Usage). Patient had the following side effects: pancreatitis on Apr 30, 2007 from UNITED STATES Additional patient health information: Male patient , 49 years of age, weighting 156.1 lb, . Peginterferon dosage: . During the same period patient was treated with FLUOXETINE CAP (View Fluoxetine Cap Review and Fluoxetine Cap Label ), RIBAVIRIN TAB (View Ribavirin Tab Review and Ribavirin Tab Label ). Patient was hospitalized.

5017528-6 | Agitation, Anxiety, Incorrect Dose Administered, Myalgia, Therapeutic Response Decreased, Treatment Noncompliance
Adverse event was reported on Jun 01, 2006 by a Male patient taking Peginterferon (View Usage) (Dosage: 120mcg Sc Q 7 D) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , 51 years of age, weighting 176.4 lb, After Peginterferon was administered, patient had the following side effects: agitation, anxiety (What is anxiety?), incorrect dose administered, myalgia, therapeutic response decreased, treatment noncompliance. During the same period patient was treated with RIBAVIRIN (600mg Po Bid) (View Ribavirin Review and Ribavirin Label ). Patient was hospitalized.

4822635-4 | Depression
on Nov 03, 2005 Male patient from UNITED STATES , 52 years of age, weighting 233.0 lb, was treated with Peginterferon (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?). Peginterferon dosage: .